Browse Obstetrics/Gynecology Articles by Topic

Clinicians Can Follow Recommendations to Better Serve Transgender Populations

Family planning clinicians and obstetrician/gynecologists likely will see transgender or gender-diverse patients seeking contraceptive care. Clinicians should learn more about transgender and gender-diverse patients to better inform their care of these populations.

Guidance Helps Clinicians Counsel Transgender Patients on Contraception

One of the challenges facing family planning clinics and obstetricians/gynecologists when serving transgender and gender-diverse patients is the lack of research and evidence-based guidelines to inform their clinical decisions. More research is needed about contraceptive needs and health effects on transgender and gender-diverse people, experts say.

Elagolix, Estradiol, and Norethindrone Acetate Capsules (Oriahnn)

Elagolix-EN should be prescribed to manage heavy menstrual bleeding associated with uterine leiomyomas (fibroids) in premenopausal women.

We’d Love to Hear From You!

Please complete our annual reader survey (https://bit.ly/2XYHWdM).

A Note from OB/GYN Clinical Alert’s New Editor

Rebecca Allen, MD, MPH, begins role as editor.

A New Treatment for Recurrent Bacterial Vaginosis?

In this randomized, controlled trial of 228 women, Lactobacillus crispatus CTV-05 (Lactin-V) applied vaginally for 11 weeks reduced the incidence of recurrent bacterial vaginosis from 45% in the placebo arm to 30% in the Lactin-V arm.

Fezolinetant Shows Positive Response in Vasomotor Symptoms Associated with Menopause

A phase 2b trial using seven dosing regimens of a novel neurokinin-3 receptor antagonist, fezolinetant, shows statistically significant improvement in vasomotor symptoms vs. placebo in postmenopausal women.

Does a Standardized Recovery Bundle After Cesarean Delivery Decrease Length of Stay?

Implementation of an enhanced recovery bundle after cesarean delivery reflected diverse positive outcomes. However, length of stay was reduced only by an average of two hours.

Is RhoGAM Needed for Rh-Negative Women Experiencing First-Trimester Pregnancy Loss or Induced Abortion?

In this prospective cohort pilot study, the authors validated a flow cytometry protocol for detecting fetal red blood cells and determined that fetal red blood cell exposure in first-trimester uterine aspiration was well below the calculated threshold for maternal Rh sensitization.

Study Reveals Low Rate of Contraceptive Use in Women with Recent Preterm Births

Medicaid claims data among a North Carolina cohort show that women were less likely to fill a contraceptive claim within 90 days after preterm birth. Investigators theorized it would be harder for women to access contraception after a preterm birth because they would be caring for a medically fragile infant. Also, women who deliver preterm experience shorter pregnancies, which means there is less time for a conversation with their healthcare providers about contraception.